Neuro Imaging

Neuro imaging produces images of the structure or activity of the nervous system, usually the brain. It uses techniques like magnetic resonance imaging (MRI) and computerized tomography (CT).

Oxford University Research Brain MRI Resting-state fMRI Parkinson's
News | June 20, 2014

June 20, 2014 — Oxford University researchers funded by Parkinson's UK have developed a simple and quick...

New Data Presented on Neuraceq Amyloid Plaque Imaging Agent at SNMMI 2014
News | June 16, 2014

June 16, 2014 — Piramal Imaging released details from research presented at the 2014 annual meeting of the Society...

Feature | June 11, 2014

June 11, 2014 — Many people develop depression in the latest stages of life, but until now doctors had no idea that...

Tyler Davis, assistant director of Texas Tech University's Neuroimaging Institute and assistant professor of psychology

News | June 09, 2014

June 9, 2014 — When it comes to familiarity, a slew of memories including seemingly unrelated ones can come flooding...

Technology | June 09, 2014

June 9, 2014 — At the 2014 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 7-...

News | May 19, 2014

May 19, 2014 — GE Healthcare and CorTechs Labs announced the signing of a strategic joint-marketing agreement at the...

News | May 12, 2014

May 12, 2014 — AC Immune SA and Piramal Imaging, a division of Piramal Enterprises Ltd., have entered into an...

News | April 29, 2014

April 29, 2014 — GE Healthcare announced the first seven markets where Vizamyl (Flutemetamol F18 injection), a...

News | April 22, 2014

April 22, 2014 — Loyola University Medical Center is now offering patients the most advanced...

News | April 17, 2014

April 17, 2014 — ICB Intl. Inc., (ICBI), announced the development of a tracer for imaging alpha-synuclein (a-Syn)...

Neuraceq, florbetaben, F18, F-18, Piramal, alzheimer's

A comparison of brain images showing positive and negative scans for the presence of beta-amyloid plaques using the Neuraceq (florbetaben F-18) radiotracer.

Technology | March 20, 2014

March 20, 2014 — The U.S. Food and Drug Administration (FDA) approved a third beta-amyloid plaque positron emission...

Plaques in Brain Scans Forecast Cognitive Impairment
News | March 18, 2014

March 18, 2014 — Brain imaging using ...

MRI Systems Parkinson's Disease Diagnosis

Top row: 7-T three-dimensional multiecho susceptibility-weighted in vivo images of SN in healthy 64-year-old man, located between the crus cerebri (a) and the red nucleus. Axial sections perpendicular to the floor of fourth ventricle are obtained at level of the inferior third of the red nucleus (level I), at the level of decussation of superior cerebellar peduncles (e) (level II), and at the level of the inferior colliculi (level III). At level I, SN appears as homogeneous hypointense structure in the medial part of the cerebral peduncle, and is laterally constituted by a hyperintense oval area between two hypointense layers (c1). At level II, a trilaminar organization of the SN with a central hyperintense layer (b) between two hypointense tiers (c and d) is detectable. At level III, the dorsal hypointense lamina could be detected as a small residual lateral hypointense area, while the hyperintense layer fades into the isointense cerebral peduncle. Bottom row: 7-T three-dimensional multiecho susceptibility-weighted in vivo images of the SN in PD patients. The loss of normal anatomy of the SN in a 61-year-old man with PD is characterized by the disappearance of the oval-shape bright spot in the lateral part of the SN at level I and by the loss of the hyperintense intermediate layer of the SN at level II. HC = healthy subject. Image from the Radiological Society of North America.

Feature | March 06, 2014

March 6, 2014 — Research shows that ultra-high-field...

Alzheimer's Disease Clinical Trial/Study PET Systems MRI
News | February 27, 2014

February 27, 2014 — People who are dementia-free but have two parents with Alzheimer's disease may show signs of the...

Invivo CorTechs Labs NeuroQuant MRI System Advanced Visualization
News | February 04, 2014
February 4, 2014 — CorTechs Labs Inc. renewed and expanded its partnership and distribution agreement with Invivo Corp...
News | February 03, 2014
February 3, 2014 — The Center for Tomography Research Laboratory (CTECH Labs) introduced its latest technology in brain...
Michael J. Fox Foundation Leads Charge to Develop Alpha-Synuclein PET Tracer to Image Parkinson's Disease Biomarker
News | December 20, 2013

The pursuit of an imaging tool to visualize the protein alpha-synuclein, the hallmark pathology of Parkinson's...

Vizamyl, flutemetamol, FDA, GE

Vizamyl (flutemetamol F-18) uptake shown in brains of patients who are normal and full of amyloid plaque.

Technology | October 25, 2013
October 25, 2013 — The U.S. Food and Drug Administration (FDA) today approved Vizamyl (flutemetamol F 18 injection), a...
nuclear imaging PET systems radiopharmaceuticals alzheimer's association
News | October 03, 2013

October 3, 2013 — The Alzheimer's Association is disappointed by the Centers for Medicare & Medicaid Services (...